Selling Your Business to a Growth Equity Investor: What Owners Need to Know
By CT Acquisitions Editorial Team, reviewed by senior M&A advisors. Last reviewed: June 2026.
Selling to a growth equity investor usually means selling a minority stake (20% to 49%) rather than the whole company, so you keep operational control, take partial liquidity off the table, and use the investor’s capital and network to scale. Growth equity deals in 2026 price at 5x to 10x forward revenue for SaaS and recurring-revenue businesses, or 8x to 14x EBITDA for profitable services and industrials, according to PitchBook’s Q1 2026 US PE Breakdown. Named firms in the category include Insight Partners, General Atlantic, TA Associates, Summit Partners, Spectrum Equity, JMI Equity, Warburg Pincus, and Susquehanna Growth Equity.
This guide covers how growth equity works, how it differs from buyout private equity and venture capital, what valuations and terms actually look like in 2026, and the mechanics of running a growth equity process from teaser to close.
What is a growth equity investor?
A growth equity investor is a private equity fund that buys minority stakes (typically 20% to 49%) in profitable, established companies that need capital and expertise to accelerate expansion. Growth equity sits between venture capital (which funds unprofitable early-stage companies) and buyout private equity (which acquires controlling stakes, usually with debt). The CAIA Association classifies growth equity as a distinct strategy with a target IRR of 20% to 25%, meaningfully lower loss ratios than VC, and hold periods of four to seven years. The American Investment Council tracks the industry’s contribution to US GDP through its member firms, and reports that growth equity capital deployed into US businesses hit a record $186 billion in 2024.
Growth equity firms want companies that already work. The target is usually generating $10M to $200M in revenue, growing 20% or more per year, near or at profitability, and led by an owner-operator who plans to stay through the next stage. The check size ranges from $20M to $500M depending on the firm.
Who are the biggest growth equity firms in 2026?
The largest dedicated growth equity managers by assets under management include Insight Partners (managing $90 billion, per Insight’s firm page), General Atlantic ($97 billion, per General Atlantic’s site), TA Associates ($65 billion), Summit Partners ($52 billion), and Warburg Pincus ($86 billion, per Warburg’s firm overview). Specialty growth equity firms include Spectrum Equity (technology), JMI Equity (B2B software), Susquehanna Growth Equity (fintech, information services), Level Equity (software), Providence Strategic Growth (software), and Vista Equity Partners’ Endeavor Fund (enterprise software minority stakes).
| Firm | AUM (2026) | Typical Check | Sector Focus |
|---|---|---|---|
| Insight Partners | $90B | $25M to $500M | Software, ScaleUp |
| General Atlantic | $97B | $50M to $500M | Tech, consumer, financial services |
| TA Associates | $65B | $70M to $500M | Tech, healthcare, financial services |
| Summit Partners | $52B | $25M to $500M | Growth-stage across sectors |
| Warburg Pincus | $86B | $100M to $1B | Global growth, all sectors |
| Spectrum Equity | $8B | $25M to $150M | Internet, software, information |
| JMI Equity | $7B | $25M to $200M | B2B software |
| Susquehanna Growth Equity | $3B | $25M to $150M | Fintech, information services |
| Level Equity | $4B | $15M to $75M | Software, information |
| Providence Strategic Growth | $9B | $25M to $200M | Software, tech-enabled services |
How does the current growth equity market look going into 2026?
The growth equity market entered 2026 with more dry powder than deployment capacity. PitchBook’s 2025 Annual US PE Breakdown reports $1.2 trillion of US private equity dry powder as of Q4 2025, with growth equity strategies holding an estimated $310 billion of that. Fundraising in growth equity remains bifurcated: mega-funds (Warburg Pincus Global Growth XIV closed at $17.3B, per a Reuters report; TA Associates XV closed at $16.5B in 2024, per TA press releases) got funded, while sub-$2B first-time funds struggled.
Deal activity through Q3 2025 showed 1,847 US growth equity investments totaling $91B, down from 2,264 deals in the same period of 2024 but higher in dollars per deal. The Bain & Company Global Private Equity Report 2025 attributes this to growth equity firms focusing on larger, later-stage deals as valuations moderated and public comps stabilized.
How high are growth equity multiples in 2026?
Software growth equity multiples compressed from a 2021 peak of 18x to 25x forward ARR down to a 2025 median of 6.9x for the BVP Nasdaq Emerging Cloud Index, per Bessemer’s Cloud Index. Private growth equity SaaS deals in 2025 priced at 7x to 12x forward ARR for Rule-of-40 businesses, and 4x to 7x for slower-growth or lower-margin SaaS, per Sacra’s private company benchmarking. Healthcare services growth deals held up better, with a 2025 median of 11.4x EBITDA per PitchBook. Consumer growth equity multiples fell to 6x to 8x revenue after 2022 highs, per PwC deal insights.
How is selling to a growth equity investor different from a full sale?
Selling to a growth equity investor is a partial exit, not a full sale. You typically sell 20% to 49% of your equity for a mix of primary capital (new money into the company to fund growth) and secondary capital (cash out to existing shareholders). You keep majority ownership, keep your CEO or founder title, keep operating control, and set up a second larger exit in four to seven years when the whole company gets sold. A full sale to a strategic acquirer or buyout PE firm transfers 100% of equity, gives you full liquidity today, and typically ends your day-to-day role within 12 to 36 months.
| Deal Attribute | Growth Equity | Buyout PE (Full Sale) | Strategic Sale |
|---|---|---|---|
| Ownership sold | 20% to 49% | 60% to 100% | 100% |
| Owner keeps control | Yes (with governance) | No | No |
| Debt used | Little or none | 4x to 6x EBITDA | Depends on buyer |
| Owner keeps job | Yes, 4 to 7 years | 2 to 3 year transition | 12 to 36 month earnout |
| Cash today (owner) | Partial (secondary) | 60% to 80% at close | Up to 100% at close |
| Second bite of apple | Yes (main appeal) | Rollover equity, smaller | Usually no |
| Typical valuation multiple | 5x to 10x revenue (SaaS), 8x to 14x EBITDA | 6x to 12x EBITDA | Often premium (strategic synergies) |
| Board seats given up | 1 to 2 investor seats | Board reconstituted | Board dissolved |
The trade you are making: you accept a lower absolute check today in exchange for keeping control and getting a second, much larger check in four to seven years when the whole company gets sold at a higher valuation. This works when you believe your business can double or triple in value with the growth capital and investor operating support. It does not work if you are burned out, if the business has plateaued, or if you want a clean break.
Growth equity vs private equity vs venture capital: what actually differs?
Growth equity, buyout private equity, and venture capital target three different life stages and use three different playbooks. Venture capital funds unprofitable early-stage companies with a high failure rate. Growth equity funds profitable scaling companies with a low failure rate. Buyout private equity acquires mature companies (often with leverage) and rebuilds them for a 3-to-5-year exit. The NVCA 2025 Yearbook tracks VC returns; PitchBook and Cambridge Associates benchmark PE and growth equity separately.
| Attribute | Venture Capital | Growth Equity | Buyout PE |
|---|---|---|---|
| Target company stage | Seed to Series C | Series D+ or bootstrapped, profitable | Mature, cash-generating |
| Revenue at investment | $0 to $20M | $10M to $200M | $25M+ EBITDA |
| Profitability required | No | Near or at breakeven | Yes, positive EBITDA |
| Ownership stake | Minority (5% to 25%) | Minority (20% to 49%) | Majority (60% to 100%) |
| Capital source | All equity, no debt | Mostly equity | Equity + 4x to 6x EBITDA debt |
| Loss rate on investments | 40% to 60% | 5% to 15% | 5% to 10% |
| Target gross IRR | 30%+ | 20% to 25% | 20% to 22% |
| Hold period | 7 to 10 years | 4 to 7 years | 3 to 5 years |
| Board control | 1 seat, observer | 1 to 2 seats, protective rights | Board control |
For a deeper comparison, see our full explainer on growth equity vs private equity.
How much is my business worth to a growth equity buyer?
Growth equity valuations follow two industry-standard formulas depending on your business model. SaaS and recurring-revenue businesses get priced at 5x to 10x forward (next-12-month) revenue, adjusted for growth rate and gross margin. Cash-generating services, industrials, and hybrid businesses get priced at 8x to 14x trailing-twelve-month EBITDA, adjusted for growth, margin, and end-market attractiveness. Actual 2026 multiples per Mergers & Inquisitions and PitchBook confirm this range.
The Rule of 40 and revenue multiples for SaaS
The Rule of 40 says that growth rate percentage plus profit margin percentage should sum to 40 or higher. A SaaS business growing 60% per year at negative-20% margin (Rule of 40 = 40) and one growing 20% per year at 20% margin (Rule of 40 = 40) get similar valuation floors. Above 40, revenue multiples climb steeply. Bessemer Venture Partners’ State of the Cloud 2025 reports the median EV/NTM revenue multiple for public cloud companies at 6.9x, with best-in-class (Rule of 40 above 60) trading at 12x to 15x.
| Business Profile | Growth Rate | Gross Margin | Typical Revenue Multiple |
|---|---|---|---|
| Best-in-class SaaS | 50%+ YoY | 80%+ | 10x to 15x forward revenue |
| Growth SaaS | 30% to 50% YoY | 70% to 80% | 7x to 10x forward revenue |
| Mature SaaS | 15% to 30% YoY | 65% to 75% | 4x to 7x forward revenue |
| Slow-growth SaaS | Under 15% YoY | 60% to 70% | 2x to 4x forward revenue |
| Tech-enabled services | 20% to 40% YoY | 40% to 60% | 2x to 4x revenue OR 10x to 14x EBITDA |
EBITDA multiples for services, industrials, and hybrid
Cash-generating businesses outside pure SaaS get valued on EBITDA. A 2026 growth equity deal on a healthcare services roll-up with 25% EBITDA margins and 20% organic growth typically prices at 11x to 13x trailing EBITDA. A niche industrial with 15% margins and 10% growth prices at 8x to 10x. Our full framework on how to value a business covers the underlying math.
How does a growth equity investor make money?
Growth equity investors make money by buying a minority stake at one valuation, adding capital and operating support to accelerate revenue and margin, and selling the whole company (or their stake) at a much higher valuation four to seven years later. The math relies on multiple expansion (higher multiple at exit than at entry), revenue growth (a bigger business at exit), or both. A typical target: 3x MOIC (multiple on invested capital) or 25% IRR gross of fees, per CAIA benchmarks.
The math on a $50M growth equity check
Assume a $200M enterprise value business gets a $50M growth equity investment for 25% ownership (post-money valuation $200M). Over five years, revenue grows from $30M to $90M, EBITDA from $6M to $20M. Exit valuation at 12x EBITDA = $240M enterprise value. The investor’s 25% stake is worth $60M. But this ignores dilution, secondary buyouts, and preferred stock conversion. In practice, growth equity firms structure participating or non-participating preferred stock, sometimes with a liquidation preference, to protect downside. The NVCA Model Legal Documents govern most preferred stock structures.
What terms should I expect in a growth equity term sheet?
Growth equity term sheets typically include preferred stock class, 1x non-participating liquidation preference, weighted-average anti-dilution, one or two investor board seats, protective covenants over major decisions, information rights, drag-along and tag-along rights, and a right of first refusal on future rounds. The NVCA Model Legal Documents (2024 update) are the industry-standard baseline, though growth equity firms customize heavily.
Preferred stock structure
Growth equity investors buy preferred stock, not common. Preferred stock gets paid first in a sale (liquidation preference), converts into common if that would produce a better outcome, and carries protective voting rights. A 1x non-participating preference means: on exit, the investor gets back their money OR their equity percentage, whichever is higher. A 1x participating preference means: they get their money back PLUS their equity percentage on top (double-dip). Owners should push hard against participating preferences in growth equity deals, since the deal is not distressed. Data from Wilson Sonsini’s Entrepreneurs Report and Cooley Go’s private deal terms tracker shows that 1x non-participating remains the standard in 87% of growth equity deals over $25M in 2024 and 2025.
| Term | Owner-Friendly | Standard | Investor-Friendly |
|---|---|---|---|
| Liquidation preference | 1x non-participating | 1x non-participating | 1x participating, capped at 3x |
| Anti-dilution | Broad-based weighted average | Broad-based weighted average | Full ratchet |
| Board seats (investor) | 1 seat, no majority | 1 to 2 seats | 2 seats + independent chair |
| Protective provisions | Major sale, new capital, budget | Above + comp, hiring executives | Above + regular ops decisions |
| Redemption right | None | None, or after 7 years at cost | 5-year mandatory redemption |
| Pay-to-play | None | None | Mandatory follow-on |
| ROFR / co-sale | Standard | Standard | Broad transfer restrictions |
Board seats and governance
A typical growth equity deal gives the investor one or two board seats. If the deal is 30%+ ownership, expect two seats. Board composition often becomes: two founder/management seats, one to two investor seats, and one or two independent directors mutually agreed. Protective provisions (things the company cannot do without investor approval) usually cover: selling the company, raising new capital, taking on major debt, changing the budget by more than 10%, hiring or firing the CEO or CFO, and materially changing the business plan.
Secondary vs primary capital split
Primary capital goes into the company balance sheet to fund growth (hiring, product, acquisitions). Secondary capital goes to existing shareholders (you and any early investors) as cash-out. Growth equity deals typically run 70% to 100% primary and 0% to 30% secondary. If you want more secondary (personal liquidity), expect the investor to take a bigger stake or negotiate a lower price. Insight Partners and General Atlantic have both publicly discussed maximum secondary caps of around 30% to 40% of total check size on their Insight ScaleUp Society and General Atlantic content.
Is growth equity right for my business? A qualification checklist
Growth equity fits businesses that are past the survival stage, growing meaningfully, and led by owner-operators who want to keep building. It does not fit businesses that are declining, businesses where the owner wants a clean exit, or businesses too small for institutional investors to underwrite. Use this checklist to self-qualify before spending time on a process.
- Revenue over $10M. Growth equity funds rarely write checks into businesses with revenue below $10M. Insight, TA, General Atlantic, and Warburg Pincus all set higher floors, typically $25M+ ARR for SaaS. Smaller businesses should look at lower-middle-market PE or search funds.
- Growth over 20% YoY. Sub-20% growth pushes you into buyout PE territory (or public markets). Growth equity firms underwrite to 25%+ IRR, which requires meaningful growth acceleration post-investment.
- Near or at profitability. Growth equity is not venture capital. Investors want to see a path to strong EBITDA margins or cash flow within 24 months. Deeply unprofitable businesses need to look at late-stage VC.
- Owner wants to stay. The founder or CEO needs to sign a four-to-seven-year commitment. If you want out in 12 to 24 months, take a full sale instead.
- Clear use of capital. You need a specific $10M+ investment thesis: three new sales reps in Europe, one product line acquisition, or a major platform rebuild. “General working capital” does not fly.
- Defensible moat. Growth equity firms want businesses that will still be winning in five years. Look at retention, gross margin, and switching costs.
- Clean cap table. A messy cap table (dozens of angels, complex preferred structures, unresolved employee options) delays or kills deals. Fix this before running a process.
How do I run a growth equity process from start to finish?
A well-run growth equity process runs 4 to 6 months from prep to close, and the outcome depends heavily on the pre-process work you and your advisor do before any investor sees your name. The process has five stages: (1) preparation and materials, (2) outreach and initial meetings, (3) management presentations and process letter, (4) diligence and term sheet, and (5) definitive agreements and close. Sell-side M&A advisors run this process; see sell-side advisory and why hire an M&A advisor for the advisor’s role.
Stage 1: Preparation (weeks 1 to 6)
The preparation stage is where the deal is won or lost. You and your advisor produce a Confidential Information Memorandum (CIM, typically 40 to 80 pages), a 15-to-25-slide management presentation, a full financial model with 5-year projections, a data room populated with contracts, financials, employee data, and legal documents, and a target buyer list of 30 to 80 growth equity firms segmented by fit.
Stage 2: Outreach (weeks 5 to 10)
Your advisor sends a blinded teaser (2-page anonymous summary) to the target list. Interested firms sign an NDA and receive the CIM. Typical response rates run 30% to 50% NDAs signed out of teasers sent, then 10% to 20% of NDA signers advancing to initial calls, per typical process metrics.
Stage 3: Management presentations and process letter (weeks 10 to 14)
Firms that pass initial calls attend 90-minute management presentations. Your advisor then sends a process letter setting the IOI (indication of interest) deadline, format, and required content: valuation, structure, sources and uses, key conditions, timing. Expect 5 to 15 IOIs from 30 to 60 initial meetings.
Stage 4: Diligence and term sheet (weeks 14 to 20)
Your advisor selects 3 to 5 firms to advance based on IOI valuation and fit. These firms conduct deep diligence: commercial (customer calls, market sizing), financial (Quality of Earnings from a firm like Grant Thornton, RSM, or BDO), legal (contracts, IP, employment), and technical (product architecture, security). At the end of diligence, remaining firms submit final term sheets. You pick one.
Stage 5: Definitive agreements and close (weeks 20 to 24)
Lawyers draft the Stock Purchase Agreement, Investors’ Rights Agreement, Voting Agreement, and Right of First Refusal Agreement (mostly modeled on NVCA standards). Confirmatory diligence closes, escrow gets set up (see escrow holdback), working capital adjustments get finalized (see net working capital adjustment), and the deal closes. Wire hits the account.
What does the growth equity due diligence process actually cover?
Growth equity due diligence is more surgical than buyout PE diligence, since the investor is not taking control and cannot rebuild the company. Diligence focuses on unit economics, retention, market size, competitive position, management depth, and downside protection. Expect 60 to 90 days from term sheet to close.
Commercial due diligence
Commercial diligence usually involves an external strategy firm (Bain, L.E.K., Alix, or a boutique) calling 20 to 40 of your customers, mapping the competitive landscape, sizing the TAM, and stress-testing your growth assumptions. Expect the firm to build a bottoms-up market model, do win/loss analysis on your last 20 deals, and interview lost customers. Total spend: $200K to $500K, paid by the investor.
Financial due diligence (Quality of Earnings)
A Quality of Earnings report (QoE) from Grant Thornton, RSM, BDO, EY-Parthenon, or similar validates your reported EBITDA, revenue, and cash flow. QoE typically adjusts EBITDA for non-recurring items, owner comp normalization, and accounting policy changes. Expect the QoE to reduce your reported EBITDA by 5% to 20%. Cost: $100K to $250K, paid by investor. See guidance from the AICPA on financial due diligence standards and the Grant Thornton QoE methodology overview. Common QoE adjustments: reclassifying capitalized R&D as expense, removing one-time COVID-era PPP forgiveness gains, normalizing owner compensation to market, and removing related-party transaction margin.
Legal due diligence
Investor’s counsel (Kirkland, Cooley, Latham, Goodwin, Wilson Sonsini, or Fenwick) reviews every material contract, IP filing, employment agreement, litigation matter, cap table, tax filing, and corporate record. Expect them to find issues. Common items: unassigned IP (contractor invention assignments), missing customer contract signatures, tax exposure from state nexus, and employment classification (contractor vs employee) exposure. The ABA Business Law Section publishes annual private target M&A deal points studies that document how these findings translate into indemnity caps, escrow sizing, and price adjustments. See also our guides on material adverse effect clauses and earnout structures that often get triggered by legal diligence findings.
Technical and product due diligence
For SaaS and tech-enabled businesses, expect a CTO-level review of your product architecture, security posture, tech debt, and engineering team. Firms like Insight Partners, TA, and General Atlantic all have in-house technical operating partners. Common findings: SOC 2 gaps, tech debt from monoliths, security vulnerabilities in customer-facing endpoints, and reliance on single-vendor dependencies.
What are common negotiation pitfalls for first-time growth equity sellers?
First-time growth equity sellers routinely give up leverage in five predictable places: post-money valuation vs pre-money confusion, option pool sizing before or after the money, participating vs non-participating preferences, board control creep through protective covenants, and drag-along thresholds that let a minority investor force a future sale. Avoiding these requires an experienced M&A advisor and a specialist corporate lawyer with growth equity reps.
Pre-money vs post-money valuation
A $200M pre-money valuation with a $50M investment = $250M post-money, so the investor owns 20%. A $200M post-money valuation with a $50M investment = $150M pre-money, so the investor owns 25%. Owners routinely confuse these and give up 5% to 10% of the company. Always clarify which basis the term sheet is using.
Option pool math (the “pre-money option pool” trick)
Investors typically require an option pool to be created or topped up before the investment closes, sized for future employee hiring. If the pool is set up pre-money, all the dilution falls on existing shareholders (you). If it is set up post-money, everyone shares dilution. On a $200M pre-money deal with a 10% option pool required, pre-money option pool costs the founder around $20M of value. Post-money costs everyone proportionally. Negotiate hard for post-money.
Participating vs non-participating preferences
Non-participating (1x): on a $500M exit with a $50M investment for 25% ownership, the investor gets the greater of $50M (return of capital) or $125M (25% of $500M). They take $125M. Participating (1x): they get $50M back first, then 25% of the remaining $450M = $112.5M, total $162.5M. Participating preferences steal $37.5M of your money on this exit. In healthy growth equity deals, non-participating is standard.
Protective provisions creep
Reasonable protective provisions: sale of the company, new preferred stock, dividends, major debt (over $5M or 1x EBITDA), amendment of charter. Unreasonable: any executive hire, any budget change, any customer contract over $500K, opening a new office. Investors will start with the aggressive list and negotiate down. Push back hard.
Drag-along and forced sales
Drag-along rights let a majority of preferred shareholders force common shareholders to vote for a sale. Standard threshold: 66% of preferred + majority of the board. Aggressive: any preferred majority, no board approval. The concern: your growth equity investor can trigger a sale in year 4 to force liquidity for their fund’s LPs, even if you would rather wait.
Tax planning for growth equity sellers (QSBS, F-reorganization)
Growth equity secondary proceeds may qualify for QSBS (Qualified Small Business Stock) treatment under IRC Section 1202, which can exclude up to $10M or 10x basis from federal capital gains tax on the eligible portion, per the IRS guidance on Section 1202. The One Big Beautiful Bill Act (OBBBA) passed in 2025 raised the QSBS exclusion cap to $15M and made the exclusion permanent. See our full guide to QSBS and Section 1202. To qualify, the stock must be original-issue C-corp stock, held over 5 years, in a business with under $75M of assets at issuance (raised from $50M under OBBBA).
F-reorganization for LLC and S-corp sellers
If your business is an LLC or S-corp, growth equity investors typically require conversion to a C-corp before investing (they cannot own preferred stock in a pass-through). An F-reorganization under IRC 368(a)(1)(F) lets you convert without triggering a taxable event, and lets you start the QSBS 5-year clock on the new C-corp stock. See F-reorganization and Type C reorganization for structure details. This planning needs to happen 12 to 24 months before the growth equity investment to maximize benefit. The IRS Section 368 rules are available in the 2024 IRS revenue procedure guidance.
Rollover equity and tax deferral on secondary proceeds
Growth equity secondary proceeds are generally taxed as capital gains, but the split between long-term (over 1 year hold, 20% federal max) and short-term (37% federal max) matters enormously. Owners with vested stock over 5 years old get long-term treatment on the full secondary. Section 1045 rollovers under IRC 1045 let sellers defer QSBS gain by rolling into new QSBS-qualified stock within 60 days, per IRS guidance. State tax treatment varies widely: California does not conform to QSBS (full state tax applies), while Massachusetts, New Jersey, and Pennsylvania partially conform, per the Tax Foundation state conformity tracker.
What happens after the growth equity investor comes in?
After close, the growth equity investor deploys their operating playbook: quarterly board meetings, monthly financial reporting, KPI dashboards, sometimes a new CFO or VP of Sales placement, and access to their portfolio company network. Insight Partners has publicly discussed its Onsite operating team (over 130 people, per Insight Onsite) covering talent, sales, product, revenue ops, and go-to-market. TA Associates, General Atlantic, and Warburg Pincus operate similar in-house operating groups.
The first 100 days
Expect the investor to run a 100-day integration planning process: KPI baseline setting, budget review, org chart mapping, sales pipeline audit, and product roadmap review. Some firms bring in outside diagnostic firms (McKinsey, Bain) to run a full commercial audit. Your job as CEO: engage constructively, do not treat the investor as an outsider, and use the operating team aggressively.
Board dynamics change
Before the investment, you probably had a founder-controlled board (you, maybe your cofounder, a friend). After close, you have a professional board with fiduciary duties: two management seats, one to two investor seats, one to two independents. Board meetings become formal, agendas circulate 5 days in advance, board packages exceed 100 pages, and executive sessions (board without management) happen at every meeting.
Preparing for the second exit
The growth equity investor is building toward exit from day one. Their fund life pressures them to exit within 4 to 7 years. Common exit paths: strategic sale (60% of exits, per PitchBook 2025 data), sale to a larger PE fund (25%), IPO (10%), and secondary buyout to another growth fund (5%). Your incentive is to grow the business as much as possible before that second sale, since the second bite is often larger than the first. McKinsey’s Global Private Markets Report 2025 tracks these exit path frequencies. S&P Global Market Intelligence maintains sponsor-to-sponsor deal databases showing that secondary buyouts have averaged 24% of PE exit volume across 2020 to 2025.
Reverse due diligence: what to check on your growth equity investor
Growth equity investors will run 60 to 90 days of due diligence on you. You should run 30 days of diligence on them. Key questions to answer before you sign: (1) What is their fund vintage and remaining life? A fund with 2 years left will pressure you to exit fast. (2) Who are their two most recent CEO changes in portfolio companies, and why? Call those CEOs. (3) What is their board vote history on major decisions? Ask three portfolio CEOs. (4) Have they ever exercised drag-along rights? Under what conditions? (5) What is their success rate on Series B to Series C progression, or on EBITDA-grower to full sale? The Private Equity Law resources and Institutional Investor’s PE coverage provide backgrounds on fund track records.
Growth equity vs recapitalization vs minority buyout: what is the actual difference?
These terms overlap and get used loosely. A minority recapitalization = growth equity investment where most or all of the check goes to existing shareholders (secondary). A minority buyout = same structure, sometimes with more governance. Growth equity investment = the standard term, with the primary/secondary split flexible. A leveraged recapitalization = uses debt to buy out shareholders while keeping the same equity structure (see LBO meaning and leveraged buyout model from scratch).
| Structure | Primary / Secondary Mix | Debt Used? | Owner Control? |
|---|---|---|---|
| Growth equity investment | 70/30 primary/secondary typical | Minimal | Yes |
| Minority recapitalization | 20/80 primary/secondary typical | Minimal | Yes |
| Leveraged recapitalization | 0/100 (all secondary) | 3x to 5x EBITDA | Yes, but debt-servicing constraints |
| Majority buyout with rollover | All secondary + rollover equity | 4x to 6x EBITDA | No (60% to 80% investor) |
Growth equity vs strategic acquirer: which pays more for scaling businesses?
Strategic acquirers (competitors, larger companies in your space, or adjacent-market entrants) can pay 15% to 40% premiums over financial buyers because they capture cost synergies, revenue synergies, and defensive value. However, strategics rarely fit growth equity intent, since they want 100% ownership and full operational integration. For sub-$50M EV businesses, strategic interest is often thinner than expected. Per Wall Street Journal deal coverage and Dealogic M&A trends, cross-border strategic activity in 2025 lagged 2021 peaks by 40% while financial sponsor activity held steadier. See our full guide on how to sell a business for the strategic path comparison.
Common growth equity firm sector theses in 2026
Growth equity firms specialize by vertical, and each firm typically publishes an annual investment thesis. Knowing the thesis before you approach lets you frame your business as an existing thesis fit, dramatically improving response rates. Public 2025 to 2026 theses include:
- Vertical SaaS. Insight, JMI, and PSG are all deploying heavily into industry-specific SaaS (construction, healthcare, legal, education). See the Silicon Valley Bank State of the Markets Report for underlying growth drivers.
- AI-enabled workflow tools. General Atlantic, TA, and Warburg have all made public statements about deploying $500M+ into AI infrastructure and applications through 2026. Track fund press through Axios Pro Deals.
- Healthcare services roll-ups. Growth equity minority investments in physician practice management and specialty clinics. Deal volume through Q3 2025 held at 2024 levels per PE Hub healthcare tracking.
- Home services and residential. HVAC, plumbing, electrical, and residential services roll-ups attracted $8.4B of growth equity in 2024, per Axial’s LMM deal reports. See our vertical guides on M&A advisory for these industries.
- Financial services and fintech. Susquehanna Growth Equity, General Atlantic, and Warburg deployed $6B+ into fintech growth in 2025. The Federal Reserve Financial Stability Report tracks the broader fintech growth trajectory.
How does CT Acquisitions approach growth equity sell-side mandates?
Growth equity processes reward advisors with two things: a real Rolodex of 40+ named growth equity partners across generalist and vertical-focused funds, and process experience running competitive minority-stake auctions. Many M&A advisors that sell full companies well have never run a growth equity process, so their outreach falls flat and terms get given up unnecessarily.
CT Acquisitions focuses on lower-middle-market sellers ($5M to $50M enterprise value) where the growth equity market gets thinner and firm selection matters more. Our approach:
- LMM-specialized outreach lists. The named firms at the top of this article (Insight, General Atlantic, TA) invest in larger deals; below $25M ARR the relevant firms are Level Equity, Providence Strategic Growth, PSG, JMI, Susquehanna, Frontier Growth, Riverside Acceleration Capital, and around 30 other LMM-focused growth firms. We segment the list by check size and thesis fit.
- Owner-aligned fee structure. Transparent monthly retainer plus a success fee tiered on outcome. No hidden fees, no double-dip. The retainer aligns to a real process, not just marketing.
- Direct advisor relationships. You work with the senior advisor running the deal, not a junior associate. Buyer calls, term sheet negotiation, and diligence coordination are handled by the same person from teaser to close.
- Full curated outreach, not marketplace listing. We do not post your deal on an online marketplace. Every buyer contact is a curated approach through a warm relationship, based on documented investment thesis fit.
- Deep vertical benches. HVAC, plumbing, MSP, dental, veterinary, landscaping, manufacturing, and SaaS practice groups mean the buyer list matches your business, not a generic template.
If you are considering a growth equity minority sale on a $10M to $50M business and want a candid read on fit, valuation, and process, schedule a 30-minute exit-readiness call at ctacquisitions.com/contact-us/. We will tell you honestly if growth equity is the right structure or if a full sale, buyout PE deal, or continued organic growth serves you better.
Frequently Asked Questions
Can I take money off the table without selling my whole company?
Yes. Growth equity investments typically include 20% to 40% secondary capital, which is cash paid directly to existing shareholders (you and any early investors) rather than into the company. On a $50M growth equity check, expect $10M to $20M as secondary. If you want more secondary, the investor will either take a bigger stake or negotiate a lower price. Full liquidity requires a full sale.
How much of my company does a growth equity investor want to buy?
Growth equity investors typically buy 20% to 40% of a company, sometimes going up to 49%. Below 20%, they lack the influence they need to protect their check. Above 49%, they cross into buyout PE territory and expect control. The sweet spot for most growth equity firms including Insight Partners, TA Associates, and General Atlantic is 25% to 35% ownership with one to two board seats and standard protective covenants.
What is a typical valuation multiple for a growth equity deal in 2026?
Growth equity valuations in 2026 run 5x to 10x forward revenue for SaaS businesses (with best-in-class Rule-of-40 companies reaching 12x to 15x) and 8x to 14x trailing EBITDA for services, industrials, and hybrid businesses. Per PitchBook’s Q1 2026 US PE Breakdown, the median growth equity entry multiple in tech is 8.2x forward revenue; in healthcare services it is 11.4x EBITDA. Deal-by-deal variation is wide.
How is growth equity different from venture capital?
Venture capital funds unprofitable early-stage companies (revenue $0 to $20M, growth over 100%, no near-term path to profit) and expects 40% to 60% of investments to fail. Growth equity funds established, profitable businesses (revenue $10M to $200M, growth 20% to 50%, near or at profitability) and expects 5% to 15% of investments to lose money. Growth equity check sizes are also 5x to 20x larger, and target IRRs are meaningfully lower (25% vs 30%+).
How long does the growth equity investor stay in my company?
Growth equity investors typically hold for 4 to 7 years, driven by fund life mechanics. Investors need to exit within their fund’s 10-year term (usually with a 2-year extension). Exit paths include strategic sale (60% of exits), sale to a larger PE fund (25%), IPO (10%), and secondary sale to another growth fund (5%), per PitchBook 2025 US exit data.
Do I have to give up board control in a growth equity deal?
No, you keep majority board control in a standard growth equity deal. A typical 5-person board is composed of two management seats (you and your COO or CFO), one to two investor seats, and one to two mutually-agreed independent directors. Protective provisions give the investor veto power over specific major decisions (sale of the company, new capital, major debt) but not day-to-day operations.
Can a growth equity investor force me to sell the company later?
Yes, through drag-along rights, but under negotiated conditions. Standard drag-along language requires approval from a majority of preferred shareholders plus a majority of the full board. If your growth equity investor holds 30% preferred and one board seat out of five, they cannot force a sale alone. Aggressive drag-along language (any preferred majority, no board required) gives one investor the power to force a sale, which owners should push back against in negotiation.
What does a growth equity investor do besides give me money?
Growth equity firms provide operating support through in-house teams. Insight Partners has 130+ Onsite operators covering talent, sales, product, and revenue operations. TA Associates has a full-time strategic resource group. General Atlantic operates a global operating partner network. Firms also provide access to portfolio company networks (introductions to potential customers, hires, and acquirers), executive recruiting help, and pattern recognition on scaling problems.
What is the difference between a growth equity investment and a leveraged recapitalization?
A growth equity investment uses mostly equity (minimal or no debt) to fund a mix of primary company capital and secondary shareholder liquidity. A leveraged recapitalization uses substantial debt (3x to 5x EBITDA) to buy out existing shareholders while keeping the same equity structure. Growth equity fits growing businesses; leveraged recaps fit stable cash-generating businesses where the owner wants liquidity without giving up ownership.